Table 4.

Association (OR) between demographic and clinical factors with achievement of target LDL-C level at follow-up Continue

	Overall (n = 151)								Non-DM (n = 68)								DM (n = 83)
	G100 OR	P value	G70 OR	P value	G55 OR	P value	G40 OR	P value	G100 OR	P value	G70 OR	P value	G55 OR	P value	G40 OR	P value	G100 OR	P value	G70 OR	P value	G55 OR	P value	G40 OR	P value
Rosuvastatin use (Ref category Atorvastatin)	1.176	0.684	2.172	0.092	2.686	0.075	1.768	0.322	0.581	0.432	0.622	0.485*	0.609	0.680*	0.486	0.389*	2.050	0.152	5.374	0.007	11.03	0.006	6.255	0.061*
Worsening of glycemic control (change in Hba1c by more than 0.5), n (%)	0.618	0.209	0.668	0.335	0.542	0.210	0.645	0.410	0.667	0.735*	0.211	0.157*	0.349	0.439*	0.426	0.673*	0.462	0. 108	0.842	0.728	0.560	0.310	0.760	0.767*
Baseline LDL > 190 mg/dl (high risk patient)	0.223	< 0.001	0.201	< 0.001	0.372	0.038	0.451	0.126	0.084	< 0.001	0.062	0.001	0.109	0.026*	0.135	0.047*	0.425	0.084	0.363	0.069	0.703	0.542	0.938	1.000*
Achieving the target 100 mg/dl at baseline	1.644	0.344	2.708	0.045	2.869	0.045*	1.839	0.331*	0.775	1.000*	0.884	1.000*	1.477	0.645*	0.681	1.000*	3.035	0.197*	5.681	0.016*	4.200	0.060*	3.169	0.106*

OR: Crude odds ratio, Shaded cells indicate statistical significance; G: Goal; DM: diabetes mellitus; NDM: none diabetes mellitus

*Fisher’s Exact test, all others were Chi-square, no one achieved the targets of G55 or G40 at baseline, so they were not included in analyses. The number who achieved the targets of 70 mg/dl at baseline was very few, so they were not included in analyses